Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

3 Shares Carrying Market-Beating Yields In 2015: AstraZeneca plc, Standard Life Plc And Aviva plc

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN), Standard Life Plc (LON: SL) and Aviva plc (LON: AV) should attract…

Read more »

Investing Articles

Big Gains To Be Made From US-Exposed Stocks Like Diageo plc, AstraZeneca plc And SABMiller plc

| David Taylor

Keen to make big gains from a rising US dollar? This Fool has some great stock picks including Diageo plc…

Read more »

Investing Articles

Why Shire PLC Has Beaten AstraZeneca plc And GlaxoSmithKline plc In 2014

| Alan Oscroft

Never mind AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK), Shire PLC (LON:SHP) is this year's big pharmaceuticals winner!

Read more »

Investing Articles

GlaxoSmithKline plc Vs AstraZeneca: Which Pharma Major Will Win In 2015?

| Peter Stephens

Should you invest in GlaxoSmithKline plc (LON: GSK) or AstraZeneca plc (LON: AZN) over the next year?

Read more »

Investing Articles

Here’s Why AstraZeneca plc And Shire PLC Are Stronger Alone

| Rupert Hargreaves

AstraZeneca plc (LON: AZN) and Shire PLC (LON: SHP) are stronger as independent companies.

Read more »

Investing Articles

Why AstraZeneca plc Should Beat GlaxoSmithKline plc In 2015

| Alan Oscroft

AstraZeneca plc (LON: AZN) has come from behind and is overtaking GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Which Company Suits Your Portfolio: AstraZeneca plc Or GlaxoSmithKline plc ?

| Rupert Hargreaves

Which is the better pick for your portfolio, AstraZeneca plc (LON:AZN), or GlaxoSmithKline plc (LON: GSK)?

Read more »

Investing Articles

As Deadline Passes, Will AstraZeneca plc Attract A New Bid From Pfizer Inc?

| Roland Head

Roland Head asks whether AstraZeneca plc (LON:AZN) still holds the same attraction for Pfizer Inc.

Read more »

Investing Articles

Is It Too Late To Buy November’s Winners, AstraZeneca plc And Vodafone Group plc?

| Harvey Jones

AstraZeneca plc (LON: AZN) and Vodafone Group plc (LON: VOD) have been on a winning streak, Harvey Jones asks whether…

Read more »

Investing Articles

2 Numbers That Could Make AstraZeneca plc A Terrific Turnaround Play

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could prove a classic contrarian winner.

Read more »

Investing Articles

Neil Woodford Praises AstraZeneca plc’s Prospects

| Rupert Hargreaves

Woodford is excited about AstraZeneca plc's (LON: AZN) future prospects.

Read more »

Investing Articles

AstraZeneca plc: Why $4.20 Is The Magic Number

| Rupert Hargreaves

AstraZeneca plc's (LON: AZN) management will be keeping a keen eye on the company's earnings.

Read more »